The Future of AI in Life Sciences: Insights from Cenevo's Latest Survey

In the rapidly evolving realm of life sciences, artificial intelligence (AI) has emerged as a transformative force. The second annual Cenevo survey, which involved over 110 industry professionals, has unveiled critical insights into the current state and future potential of AI in modern laboratories. While more labs are exploring AI applications, these technologies often remain largely experimental, with just 5% having integrated AI into their production environments.

Survey Overview

Conducted in January 2026, the Cenevo survey aimed to understand the various trends shaping digital lab operations, especially concerning AI technologies. Participants hailed from diverse areas such as research and development (R&D), clinical studies, biology, and manufacturing. The findings shed light on how laboratories are navigating the challenges and opportunities of AI adoption.

AI Adoption in Laboratories

A striking 60% of labs are either piloting or exploring AI technologies. Specifically, 57% of respondents are utilizing AI for data analysis, and one-quarter report utilizing generative AI in fully operational settings. Despite these advancements, it's noteworthy that only 5% have implemented AI-driven workflows in production processes. This indicates a cautious yet progressive approach towards incorporating AI into everyday lab functions.

Key Concerns and Challenges

Researchers have expressed significant caution regarding AI technologies. Privacy and security concerns plague 58% of the surveyed professionals, reflecting an apprehension towards fully adopting AI solutions. Furthermore, while 42% acknowledge that data quality and management issues hinder AI adoption, this marks a decline from 54% reported in the previous year. Still, it underscores ongoing challenges associated with data integrity and integration within laboratory systems.

Despite the concerns, many researchers are excited about the potential of AI to revolutionize various facets of lab operations. They prioritize its use for data interpretation, workflow automation, experiment design, and inventory management. These applications illustrate a practical approach to AI, focusing on enhancing existing processes rather than embarking on wholly autonomous technological frontiers at this time.

Investment Priorities

Lab leaders are realigning budgets to address connectivity and integration challenges. A resounding 62% of small and medium-sized organizations reported the necessity of integrating laboratory information management systems (LIMS), electronic lab notebooks (ELNs), and instruments. Rather than investing in standalone tools, organizations are prioritizing automation solutions, AI-enabled software, and robust data infrastructure to facilitate smooth operations.

Lessons from the Survey

The trends revealed by the Cenevo survey underscore a significant shift towards automation and improved data management amidst the cautious embrace of AI. The acknowledged need for enhanced connectivity reflects a collective understanding within the industry that effective data utilization is central to maximizing AI's benefits. However, a disconnect between systems remains a prevalent issue, with over half of the respondents highlighting lack of integration as a primary challenge.

Cenevo CEO Keith Hale pointed out that although the exploration of AI technologies is gaining momentum within laboratories, the practical application of these innovations is still restrained. Concerns related to fragmented data and stringent regulatory requirements are impeding widespread adoption of AI workflows. Consequently, labs are prioritizing connectivity and automation, striving for a seamless integration of AI technologies into their existing systems.

Conclusion

The future outlook for AI in life sciences appears promising yet complex. As laboratories continue navigating the challenges and opportunities presented by AI, the insights from the Cenevo survey offer a roadmap for enhancing digital lab operations. By addressing data management issues and fostering connectivity, life sciences labs can unlock the true potential of AI, driving forward innovation and improved outcomes in research and development.

In summary, Cenevo's survey serves as a vital touchstone for understanding the current landscape of AI technologies in laboratories, fostering a dialogue around the careful yet deliberate adoption of these transformative tools.